iSpecimen Inc. 8-K Report: Key Insights & Stock Details (Dec 2024)

Based on the provided XML section from the financial report, here are the extracted key pieces of information and insights:

Entity Information:

• Company Name: iSpecimen Inc.
• CIK (Central Index Key): 0001558569
• State of Incorporation: Delaware (DE)
• SEC File Number: 001-40501
• Tax ID (EIN): 27-0480143
• Address: 8 Cabot Road, Suite 1800, Woburn, MA 01801
• Phone Number: 781-301-6700
• Stock Exchange: NASDAQ
• Ticker Symbol: ISPC

Report Information:

• Report Type: 8-K (Current Report)
• Filing Date: December 27, 2024
• Date of Report: December 27, 2024

Stock Information:

• Common Stock:
• Par Value: $0.0001 per share

Context and Units:

• Context ID: As of December 27, 2024
• Currency: USD (United States Dollar)
• Shares Measurement: The report indicates shares as a unit of measurement, which suggests that the company may be reporting on share-related metrics (e.g., stock performance, issuance, or other equity-related disclosures).

Insights:

• This filing (8-K) likely reflects significant, timely information regarding iSpecimen Inc., which could be relevant to investors or stakeholders, such as financial performance updates, corporate actions, or other material events.
• The low par value of the common stock ($0.0001) could indicate that the company is in a growth phase or may have undergone multiple rounds of financing, which is common in tech and biotech sectors.
• Being listed on NASDAQ suggests that the company is subject to stringent regulatory compliance and corporate governance standards, which can provide a level of confidence for investors.

This information provides a snapshot of the company's current status as of the reporting date and highlights important identifiers and stock-related details that are crucial for investors and analysts.